Novocure says its ovarian cancer therapy did not meet main goal in late-stage trial

NovoCure

28/08/2023 12:10

Aug 28 (Reuters) - Novocure  NVCR.O  said on Monday its
therapy, in combination with a type of chemotherapy paclitaxel,
failed in a late-stage trial to meet the main goal of improving
survival rates in patients with a type of ovarian cancer. 

 (Reporting by Sriparna Roy in Bengaluru; Editing by Nivedita
Bhattacharjee)
 ((Sriparna.Roy@thomsonreuters.com;))